These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21914365)

  • 1. [Relationship between SGRQ score and pulmonary function and its influencing factors in patients with chronic obstructive pulmonary disease].
    Liu R; DU YP; He B
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(22):1533-7. PubMed ID: 21914365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of the quality of life with the inspiratory capacity in patients with chronic obstructive pulmonary disease].
    Shen N; Yao WZ; Liu Z; Wang XH; Hao ZT; Liu XF
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):261-4. PubMed ID: 20646455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease.
    Hajiro T; Nishimura K; Tsukino M; Ikeda A; Oga T
    Respir Med; 2000 Sep; 94(9):841-6. PubMed ID: 11001074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
    Kurashima K; Hara K; Yoneda K; Kanauchi T; Kagiyama N; Tokunaga D; Takayanagi N; Ubukata M; Sugita Y
    Respirology; 2009 Mar; 14(2):239-44. PubMed ID: 19210650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R; Make B
    COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of St George's respiratory questionnaire in evaluating the life quality of Chinese patients with chronic obstructive pulmonary disease].
    Lu WX; Zhang YJ; Hu B; Ma Y; Zhu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Apr; 26(4):195-8. PubMed ID: 12901823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
    Long H; Luo H; Chen P; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index.
    Medinas Amorós M; Mas-Tous C; Renom-Sotorra F; Rubí-Ponseti M; Centeno-Flores MJ; Gorriz-Dolz MT
    Chron Respir Dis; 2009; 6(2):75-80. PubMed ID: 19411567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of health education on the lung function and life quality in patients with stable chronic obstructive pulmonary diseases].
    Cai S; Chen P; Chen Y; Liu ZJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):189-93. PubMed ID: 16706112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
    Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
    Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
    Eguchi Y; Tateishi Y; Umeda N; Yoshikawa T; Kamoi H; Kanazawa H; Kudoh S; Hirata K; Fujimoto S
    Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Observation of the therapeutic effect on COPD of cold phlegm blocking the lung type at stable stage treated with acupoint sticking therapy in different season].
    Yang SQ; Zhang W; Li JX; Lou BD; Li XP; Li W; Huang XH; Liu XP; Yang LB; Shi WY; Cao Y
    Zhongguo Zhen Jiu; 2012 Feb; 32(2):117-22. PubMed ID: 22493913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
    Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
    N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between quality of life and morbidity and mortality in COPD patients: Two-year follow-up study.
    Yorgancioglu A; Havlucu Y; Celik P; Dinc G; Saka A
    COPD; 2010 Aug; 7(4):248-53. PubMed ID: 20673033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American translation, modification, and validation of the St. George's Respiratory Questionnaire.
    Barr JT; Schumacher GE; Freeman S; LeMoine M; Bakst AW; Jones PW
    Clin Ther; 2000 Sep; 22(9):1121-45. PubMed ID: 11048909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease.
    Nagata K; Tomii K; Otsuka K; Tachikawa R; Otsuka K; Takeshita J; Tanaka K; Matsumoto T; Monden K
    Respirology; 2012 Apr; 17(3):506-12. PubMed ID: 22257381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs.
    Foglio K; Bianchi L; Bruletti G; Porta R; Vitacca M; Balbi B; Ambrosino N
    Respir Med; 2007 Sep; 101(9):1961-70. PubMed ID: 17531455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary diseases.
    Gupta RK; Chhabra SK
    Indian J Chest Dis Allied Sci; 2002; 44(3):165-72. PubMed ID: 12206475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
    Iwasaki A; Shirakusa T; Enatsu S; Maekawa S; Yoshida Y; Yoshinaga Y
    Thorac Cardiovasc Surg; 2005 Jun; 53(3):162-7. PubMed ID: 15926096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical utility of the GOLD classification of COPD disease severity in pulmonary rehabilitation.
    Huijsmans RJ; de Haan A; ten Hacken NN; Straver RV; van't Hul AJ
    Respir Med; 2008 Jan; 102(1):162-71. PubMed ID: 17881207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.